1. Improved survival with radiotherapy in hepatocellular carcinoma with major vascular invasion: A propensity-matched analysis of Surveillance, Epidemiology, and End Results database
- Author
-
Canmei Zhong, Shiyao Chen, Qiuyan Lin, Xiaoquan Huang, Tiancheng Luo, and Xiaoqing Zeng
- Subjects
0301 basic medicine ,Male ,Cancer Research ,medicine.medical_specialty ,Carcinoma, Hepatocellular ,Epidemiology ,and End Results ,Subgroup analysis ,Kaplan-Meier Estimate ,Lower risk ,Gastroenterology ,propensity score‐match ,major vascular invasion ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,medicine ,Surveillance, Epidemiology, and End Results ,Humans ,Radiology, Nuclear Medicine and imaging ,Propensity Score ,Survival rate ,radiotherapy ,Aged ,Proportional Hazards Models ,Original Research ,Surveillance ,Neovascularization, Pathologic ,business.industry ,Liver Neoplasms ,Clinical Cancer Research ,hepatocellular carcinoma ,medicine.disease ,030104 developmental biology ,Oncology ,030220 oncology & carcinogenesis ,Hepatocellular carcinoma ,Propensity score matching ,Cohort ,Female ,business ,SEER Program - Abstract
Objectives Hepatocellular carcinoma (HCC) associated with major vascular invasion is an advanced stage disease with an extremely poor prognosis and low survival rate. Our study evaluated the survival benefit of radiotherapy (RT) in HCC patients with major vascular invasion through Surveillance, Epidemiology, and End Results database. Methods We analyzed 3181 HCC patients with major vascular invasion cases diagnosed from 2004 to 2013. Patients (N = 308) who underwent RT and patients (N = 2873) who did not receive RT were compared. We successfully analyzed patients using propensity score matching (PSM). Kaplan‐Meier and Cox‐regression analyses were applied to assess prognosis. Results The median survival time in radiation‐treated group was longer compared to the control group (7 months vs 3 months; P
- Published
- 2018